Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesVirus Isolation ProceduresCPT cpt-87253-viral-identification-after-tissue-culture
    Ask Trek AI about this page

    CPT 87253: Virus Identification by Neutralization After Tissue Culture

    CPT code 87253 describes laboratory testing where an analyst performs additional virus-specific identification, such as neutralization assays, on a virus previously isolated and presumptively identified using tissue culture techniques; service type: specialized virology identification/confirmatory testing; typical site of service: clinical virology laboratory or hospital microbiology laboratory.

    For related coverage guidance, see recent payer policy updates: Long-Acting Injectable Antiretroviral Agents for HIV, B-Hemolytic Streptococcus Testing, Human Immunodeficiency Virus (HIV) — Coverage Criteria for Testing and Resistance Assays.

    Customize your policy alerts

    Sign up for cpt 87253 policy alerts

    Get alerted when payer policies referencing 87253 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Table of contents

    Progress1 / 6

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical & Coding Specifications

    Clinical Context

    A virology laboratory receives a nasopharyngeal specimen from an inpatient with an acute viral syndrome. The specimen is processed and inoculated into appropriate cell lines for tissue culture; a laboratory analyst observes cytopathic effect and performs initial identification using immunofluorescence or rapid antigen techniques. To achieve definitive typing and confirm the viral agent, a second analyst performs additional, specific assays such as neutralization testing or targeted serologic neutralization to identify the virus strain isolated in culture. Typical workflow: specimen accessioning → culture inoculation and incubation → primary identification by the first analyst → referral to a virology specialist or second analyst for neutralization or other confirmatory tests (87253) → result verification and reporting to the ordering clinician. Typical site of service is an outpatient or hospital clinical virology laboratory within a medical center or reference laboratory. A realistic patient scenario: a hospitalized adult with fever, respiratory distress, and radiographic infiltrates whose nasopharyngeal swab yields a cytopathic effect in tissue culture; the lab performs neutralization to specifically identify influenza A subtype or adenovirus serotype for infection control and epidemiologic reporting.

    Related CPT Codes

    CPT CodeDescriptionRelationship to This Procedure
    87252Culture, fungal, bacterial or viral; isolation/identification by tissue culture, initial isolationPerformed before 87253; the initial tissue culture isolation and preliminary identification by the first analyst precedes additional specific neutralization testing.
    87254Tissue culture, cytopathic effect observation onlyMay be used for documentation of culture observation steps; relates to the culture process that yields isolates for 87253 confirmatory testing.
    87256Viral identification by immunofluorescence or antigen detection (direct or indirect)Often performed as initial identification methods; if these methods are inconclusive, 87253 neutralization is performed for specific identification.
    87498Infectious agent detection by nucleic acid, unspecified method, amplified probe techniqueMolecular tests that may be ordered alongside or instead of culture-based identification; provides complementary or confirmatory results to culture and neutralization.
    88360Special stains (e.g., for infectious agents)Ancillary pathology techniques that may be used in parallel for identification of infectious organisms in tissue; supports diagnostic correlation with 87253.

    Related Modifiers

    8 rows

    ModifierDescriptionWhen to Use
    26Modifier 26 (Professional Component) identifies and bills only the professional portion of a split service — the physician’s interpretation, report, and medical judgment — when the technical…- Use CPT Modifier -26 when you are billing only the professional component (PC) of a split‑bill eligible service—i.e., you performed the physician interpretation, medical judgment and prepared a…
    59Modifier 59 indicates a distinct procedural service when two procedures that are not normally billed together are clinically and procedurally separate. The CPT definition (as reiterated by CMS)…- Use modifier -59 to report a distinct procedural service when documentation supports that the procedure reported is not normally billed together with another service on the same day because of a…
    90Modifier ‑90 (Reference/Outside Laboratory) indicates that a laboratory test was performed by an entity other than the treating or reporting provider. The American Medical Association defines…- Use CPT modifier -90 when a laboratory test is performed by an outside/reference laboratory (an entity other than the treating or reporting physician or qualified professional) and the claim needs…
    91Modifier 91 — “Repeat Clinical Diagnostic Laboratory Test” — is appended when the exact same CPT laboratory test is performed more than once for the same patient on the same day because serial,…- Use modifier 91 when the exact same CPT laboratory test is performed more than once on the same patient on the same date because serial or repeated testing is medically necessary to monitor…
    22Modifier –22 (Increased Procedural Services) is used when a reported procedure is substantially more extensive than normally required. The CPT Manual and CMS state it may be appended only when the…- When to use: Append modifier -22 to a procedural CPT code when the service performed is substantially more extensive than the usual service described by that code — i.e., the procedure required…
    52Modifier ‑52 (Reduced Services) indicates that a service or procedure was partially reduced or omitted at the provider’s discretion, allowing reporting of the basic procedure number with a qualifier…- Use modifier -52 when a physician or qualified health professional electively reduces or omits part of a procedure or service (for example, performing fewer required views or omitting a portion of…
    53Modifier 53 (Discontinued Procedure) signals that a surgical or diagnostic service was begun by the physician but terminated because of extenuating circumstances that threatened the patient’s…- Use modifier -53 when a physician/qualified healthcare professional has started a surgical or diagnostic procedure (e.g., anesthesia administered, incision or scope insertion) and then discontinues…
    78CPT modifier -78 indicates an unplanned, related return to the operating or procedure room by the same provider during the global postoperative period. It is appended when treatment for a…- Use modifier -78 when an unplanned, related complication during the original procedure’s global postoperative period requires the patient to return to a formal operating or procedure room and the…

    Related Provider Taxonomies

    8 rows

    Taxonomy Code
    207R00000X
    363L00000X
    364ST0500X
    347E00000X
    163WC0400X
    332BD1200X
    103TE1000X
    2279P3900X

    Related Payer Policy Updates

    Specialty: Infectious Disease1 / 3

    10 rows

    PolicyPayerEffective Date
    Long-Acting Injectable Antiretroviral Agents for HIVColorado Rocky Mountain Health Plans2026-10-01
    B-Hemolytic Streptococcus TestingOscar Health2026-10-01
    Human Immunodeficiency Virus (HIV) — Coverage Criteria for Testing and Resistance AssaysOscar Health2026-10-01
    Hepatitis Testing (A, B, C, D) Coverage CriteriaOscar Health2026-10-01
    Lyme Disease Testing Coverage CriteriaOscar Health2026-10-01
    Pathogen Panel TestingOscar Health2026-10-01
    Diagnostic Testing of Common Sexually Transmitted InfectionsOscar Health2026-10-01
    Coronavirus Testing in the Outpatient SettingOscar Health2026-10-01
    Testing for Vector-Borne InfectionsOscar Health2026-10-01
    Testing for Diagnosis of Active or Latent TuberculosisOscar Health2026-10-01

    Related Codes

    CPT-87250-VIRAL-ISOLATION-IN-EMBRYONATED-EGG-OR-SMALL-ANIMAL

    CPT 87250: Viral Isolation Using Embryonated Egg or Small Animal

    CPT-87252-VIRAL-CULTURE-IDENTIFICATION-TISSUE-CULTURE

    CPT 87252: Viral Isolation in Tissue Culture

    CPT-87254-SHELL-VIAL-VIRAL-CULTURE-IMMUNOFLUORESCENCE

    CPT 87254: Shell Vial Viral Culture with Immunofluorescence

    CPT-87255-VIRAL-IDENTIFICATION-CELL-IMPACT-ANALYSIS

    CPT 87255: Viral Identification by Cytopathic Effect, Non‑Immunologic

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.